Search results for "Heart"

showing 10 items of 3201 documents

Pulsatile and steady 24-h blood pressure components as determinants of left ventricular mass in young and middle-aged essential hypertensives

2003

In order to explore the relations between left ventricular mass (LVM) and the pulsatile (pulse pressure) and steady (mean pressure) components of the blood pressure (BP) curve, 304 young and middle-aged essential hypertensive patients were studied by means of 24-h ambulatory BP monitoring and echocardiography. In the overall study population, both the BP components showed significant correlations with LVM. These correlations were unevenly distributed in the subgroups of subjects younger and in those older than 50 years. While in this latter subgroup, in multivariate analysis, both 24-h mean BP (24-MBP) (beta = 0.27; P = 0.008) and 24-h pulse pressure (24-h PP) (beta = 0.23; P = 0.02) were a…

AdultMalemedicine.medical_specialtyTime FactorsAmbulatory blood pressureHeart diseaseSystoleHeart VentriclesStatistics as TopicPulsatile flowBlood PressureBody Mass IndexPredictive Value of TestsRisk FactorsAlbuminsInternal medicineStatistical significanceInternal MedicinemedicineHumansbusiness.industryAge FactorsMiddle Agedmedicine.diseaseCircadian RhythmPulse pressureMean blood pressureBlood pressureEndocrinologyItalyPulsatile FlowHypertensionMultivariate AnalysisPopulation studyFemalebusinessJournal of Human Hypertension
researchProduct

Implantation Strategy of the Atrial Dipole Impacts Atrial Sensing Performance of Single Lead VDD Pacemakers

2002

WIEGAND, U.K.H., et al.: Implantation Strategy of the Atrial Dipole Impacts Atrial Sensing Perfor-mance of Single Lead VDD Pacemakers. Intermittent atrial undersensing is observed in a considerable percentage of patients with single lead VDD pacemakers. Analyzing the 2-year data of the Saphir Multicenter Follow-Up Study, the authors investigated predictors for the occurrence of undersensing. The study included 194 patients with high degree AV block who received a VDD pacemaker system with an identical sensing amplifier. Placement strategy of the atrial dipole was left to the discretion of the implanting physician. At the final position, atrial potential amplitudes were measured during deep …

AdultMalemedicine.medical_specialtyTime FactorsAtrial sensingSensitivity and SpecificityPacemaker systemElectrocardiographyIntraoperative fluoroscopyInternal medicineHumansMulticenter Studies as TopicMedicineHeart Atriacardiovascular diseasesAgedRetrospective StudiesAged 80 and overbusiness.industryP waveCardiac Pacing ArtificialEquipment DesignGeneral MedicineMiddle AgedDipoleHeart Blockmedicine.anatomical_structureSingle leadAtrioventricular Nodecardiovascular systemCardiologyRight atriumEquipment FailureFemaleCardiology and Cardiovascular MedicinebusinessHolter monitoringFollow-Up StudiesPacing and Clinical Electrophysiology
researchProduct

Therapeutic management in Sicilian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy and focus on the role of implanta…

2014

Arrhythmogenic Right Ventrticular Dysplasia/Cardiomyopathy(ARVD/C) is an inherited cardiomyopathy characterized by right ven-tricularmyocytelosswithfibrofattyreplacement,ahighriskofventric-ular arrhythmias (VA) and sudden cardiac death (SCD) [1]. Preventionof SCD represents the most important management strategy and theachievement of this target can be reached by different therapeuticstrategies including implantable cardioverter-defibrillator (ICD)implantation, pharmacologic therapy, catheter ablation of ventriculartachycardia (VT) and cardiac transplantation [2,3]. The aim of thisstudy is to examine the outcome of the different therapies adopted ina group of affected patients, focusing on th…

AdultMalemedicine.medical_specialtyTime FactorsCardiomyopathymedicine.medical_treatmentCardiomyopathyCatheter ablationImplantable cardioverterdefibrillatorSudden deathInternal medicinemedicineHumansMedical managementSicilySurvival rateArrhythmogenic Right Ventricular DysplasiaCardiomyopathy; Implantable cardioverterdefibrillator; Medical management; Predictors; Sudden deathSudden deathbusiness.industryPrognosisImplantable cardioverter-defibrillatormedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareDefibrillators ImplantableArrhythmogenic right ventricular dysplasiaSurvival RateTransplantationDeath Sudden CardiacTreatment OutcomeHeart failureCardiologyFemaleMorbidityCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesPredictorInternational Journal of Cardiology
researchProduct

Optimal Response to Cardiac Arrest study: Defibrillation waveform effects

2001

Abstract Introduction: Advances in early defibrillation access, key to the “Chain of Survival”, will depend on innovations in defibrillation waveforms, because of their impact on device size and weight. This study compared standard monophasic waveform automatic external defibrillators (AEDs) to an innovative biphasic waveform AED. Material and methods: Impedance-compensated biphasic truncated exponential (ICBTE) and either monophasic truncated exponential (MTE) or monophasic damped sine (MDS) AEDs were prospectively, randomly assigned by date in four emergency medical services. The study design compared ICBTE with MTE and MDS combined. This subset analysis distinguishes between the two clas…

AdultMalemedicine.medical_specialtyTime FactorsEndpoint DeterminationDefibrillationmedicine.medical_treatmentElectric CountershockEmergency NursingReturn of spontaneous circulationhemic and lymphatic diseasesInternal medicineIntensive careHumansMedicineChain of survivalCardiopulmonary resuscitationAutomated external defibrillatorAgedAged 80 and overbusiness.industryEquipment DesignMiddle Agedmedicine.diseaseSurvival AnalysisCardiopulmonary ResuscitationDefibrillators ImplantableHeart ArrestSurgeryEuropeTreatment OutcomeShock (circulatory)Ventricular fibrillationEmergency MedicineCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessResuscitation
researchProduct

Short-Term Prognosis of Juvenile Myocardial Infarction

2016

In our early research regarding the hemorheological pattern in patients with acute myocardial infarction (AMI) with a mean age of 61.45 + 10.99 years, we showed that the major hemorheological parameters were almost normalized 2 weeks after the acute event. In the last decade, we focused on hemorheological parameters in juvenile myocardial infarction (JMI), defined as AMI in patients aged 45 years, in the ‘‘Sicilian study on juvenile myocardial infarction’’. Juvenile myocardial infarction is responsible for 2% to 10% of all cases with AMI in different surveys. Juvenile myocardial infarction presents a typical pattern of risk factors and shows clinical, angiographic, and prognostic characteri…

AdultMalemedicine.medical_specialtyTime FactorsIschemic heart diseaseBlood viscosity030204 cardiovascular system & hematologyBlood rheology030218 nuclear medicine & medical imagingAnginaCoronary artery diseasePlasma03 medical and health sciences0302 clinical medicineRisk FactorsDiabetes mellitusInternal medicinemedicineHumansMyocardial infarctionAge of OnsetRisk factorNon-ST Elevated Myocardial InfarctionBlood rheology; Myocardial infarction; Ischemic heart diseaseMedicine (all); Cardiology and Cardiovascular Medicinebusiness.industryMedicine (all)HemodynamicsBlood ViscosityPrognosismedicine.diseaseMyocardial infarctionHeart failureCoronary vesselDisease ProgressionCardiologyST Elevation Myocardial InfarctionFemaleCardiology and Cardiovascular MedicinebusinessAngiology
researchProduct

Quantifying training intensity distribution in a group of Norwegian professional soccer players.

2011

Purpose:This study was designed to quantify the daily distribution of training intensity in a group of professional soccer players in Norway based on three different methods of training intensity quantification.Methods:Fifteen male athletes (age, 24 ± 5 y) performed treadmill test to exhaustion to determine heart rate and VO2 corresponding to ventilatory thresholds (VT1, VT2), maximal oxygen consumption (VO2max) and maximal heart rate. VT1 and VT2 were used to delineate three intensity zones based on heart rate. During a 4 wk period in the preseason (N = 15), and two separate weeks late in the season (N = 11), all endurance and on-ball training sessions (preseason: N = 378, season: N= 78) w…

AdultMalemedicine.medical_specialtyTime FactorsLactic acid bloodeducationLibrary sciencePhysical Therapy Sports Therapy and RehabilitationNorwegianPerceived exertionYoung AdultOxygen ConsumptionHeart Ratesoccer exercise intensity training zones training load perceived exertionSoccerTask Performance and AnalysismedicineHumansOrthopedics and Sports MedicineLactic AcidTraining loadMuscle SkeletalNorwaylanguage.human_languageTraining intensitylanguagePhysical therapyExercise TestPhysical EnduranceVDP::Medical disciplines: 700::Sports medicine: 850PsychologyPulmonary Ventilationhuman activitiesBiomarkersMuscle ContractionInternational journal of sports physiology and performance
researchProduct

Large left ventricular metastatis in patient with liposarcoma.

2014

Abstract Metastasis to the heart and pericardium are rare. We present a 44-year-old male with pleural dedifferentiated liposarcoma and multiple metastases, with no previous cardiological history and/or cardiac symptoms. A transthoracic echocardiogram during the advanced stage of disease showed a lobulated, large and mobile mass, with homogeneous echogenicity, attached to the basal posterior wall of the left ventricle via a broad base and with intracavitary growth. This mass extends to inferolateral and inferoseptal wall of the left ventricle.

AdultMalemedicine.medical_specialtyTime FactorsLarge left ventricular metastasiBiopsyHeart VentriclesPleural Neoplasms030204 cardiovascular system & hematologyDoppler echocardiographyLiposarcomaMetastasisHeart Neoplasms03 medical and health sciencesFatal Outcome0302 clinical medicineHumansMedicinePericardium030212 general & internal medicinePleural Neoplasmheart metastases liposarcomamedicine.diagnostic_testbusiness.industryEchogenicityGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareEchocardiography DopplerTumor Burdenmedicine.anatomical_structureVentricleliposarcomaDisease Progressioncardiovascular systemRadiologyTransthoracic echocardiogramTomography X-Ray ComputedCardiology and Cardiovascular Medicinebusiness
researchProduct

Prognostic Value of a Comprehensive Cardiac Magnetic Resonance Assessment Soon After a First ST-Segment Elevation Myocardial Infarction

2009

ObjectivesTo evaluate the prognostic value of a comprehensive cardiac magnetic resonance (CMR) assessment soon after a first ST-segment elevation myocardial infarction (STEMI).BackgroundCMR allows for a simultaneous assessment of wall motion abnormalities (WMA), WMA with low-dose dobutamine (WMA-dobutamine), microvascular obstruction, and transmural necrosis. This approach has been proven to be useful to predict late systolic recovery soon after STEMI. Its prognostic value and the relative prognostic weight of these indexes are not well-defined.MethodsWe studied 214 consecutive patients with a first STEMI treated with thrombolytic therapy or primary angioplasty discharged from hospital. In …

AdultMalemedicine.medical_specialtyTime FactorsMagnetic Resonance Imaging CineInfarctionKaplan-Meier EstimateRisk Assessmentcardiac magnetic resonanceNecrosisPredictive Value of TestsRecurrenceRisk FactorsDobutamineInternal medicinemedicineHumansThrombolytic TherapyRadiology Nuclear Medicine and imagingcardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryAgedProportional Hazards ModelsHeart Failurebusiness.industryMyocardiumAdrenergic beta-AgonistsMiddle Agedmedicine.diseaseCoronary VesselsMyocardial ContractionTreatment Outcomemyocardial infarctionRadiology Nuclear Medicine and imagingHeart failureMicrovesselscardiovascular systemCardiologyMyocardial infarction complicationsFemaleDobutamineprognosisMyocardial infarction diagnosisCardiology and Cardiovascular MedicinebusinessTIMIMacemedicine.drugJACC: Cardiovascular Imaging
researchProduct

From heart-rate data to training quantification: a comparison of 3 methods of training-intensity analysis.

2014

Purpose:The authors directly compared 3 frequently used methods of heart-rate-based training-intensity-distribution (TID) quantification in a large sample of training sessions performed by elite endurance athletes.Methods:Twenty-nine elite cross-country skiers (16 male, 13 female; 25 ± 4 y; 70 ± 11 kg; 76 ± 7 mL · min−1 · kg−1 VO2max) conducted 570 training sessions during a ~14-d altitude-training camp. Three analysis methods were used: time in zone (TIZ), session goal (SG), and a hybrid session-goal/time-in-zone (SG/TIZ) approach. The proportion of training in zone 1, zone 2, and zone 3 was quantified using total training time or frequency of sessions, and simple conversion factors across…

AdultMalemedicine.medical_specialtyTime FactorsOperations researchLactic acid bloodPhysical ExertionPhysical Therapy Sports Therapy and Rehabilitationsession goalVDP::Medical disciplines: 700::Sports medicine: 850::Exercise techniques: 851Young Adultendurance trainingEndurance trainingHeart Ratetime in zoneHeart ratemedicineHumansOrthopedics and Sports MedicineMedical physicsLactic AcidXC skiersPhysical conditioningintensity distributionAthletesTraining intensityPhysical EnduranceFemalePsychologyPhysical Conditioning HumanInternational journal of sports physiology and performance
researchProduct

Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients

2012

A multicenter randomized open-label long-term sequential deferiprone–deferoxamine (DFP-DFO) versus DFP alone trial (sequential DFP-DFO) performed in patients with thalassemia major (TM) was retrospectively reanalyzed to assess the variation in the left ventricular ejection fraction (LVEF) [1].

AdultMalemedicine.medical_specialtyTime FactorsPyridonesHeart VentriclesThalassemiaDeferoxamineIron Chelating AgentsModels BiologicalDrug Administration Schedulechemistry.chemical_compoundInternal medicineHumansMedicineLeft ventricular ejectionDeferiproneIn patientRetrospective StudiesUltrasonographyEjection fractionbusiness.industrybeta-ThalassemiaStroke VolumeHematologymedicine.diseasehumanitieschemistryCardiologyDrug Therapy CombinationFemaleThalassemia major Left ventricular ejection fraction Deferiprone sequential deferiprone-deferoxamine Echocardiography ChelationbusinessDeferiproneAmerican Journal of Hematology
researchProduct